CI Munro Global Growth Equity F (CIG4198)
8.892
-0.06 (-0.68%)
CAD |
May 19 2022
Returns Chart
Key Stats
Customize
Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
---|---|---|---|
1.16% | 495.38M | 0.00% | 101.8% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
-5.603M | -8.03% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The fund seeks to maximize long-term capital appreciation primarily through exposure to a portfolio of growth-oriented equities issued by companies located anywhere in the world. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | CIG90198 |
Equity Style | Large Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Global Equity |
Category Index | Morningstar Gbl Mkts GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | CI Investments Inc |
Prospectus Benchmark Index | |
MSCI ACWI NR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
James Tsinidis | 3.30 yrs |
Jeremy Gibson | 3.30 yrs |
Kieran Moore | 3.30 yrs |
Nick Griffin | 3.30 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
74
-5.603M
-534.39M
Category Low
4.218B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 19, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 19, 2022.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Microsoft Corp
|
6.97% | -- | -- |
Visa Inc Class A
|
5.63% | -- | -- |
UnitedHealth Group Inc
|
4.99% | -- | -- |
Nutrien Ltd | 4.87% | 129.85 | -0.67% |
ASML Holding NV | 4.85% | 525.83 | -1.71% |
Danaher Corp
|
4.75% | -- | -- |
Alphabet Inc Class A
|
4.73% | -- | -- |
Mastercard Inc Class A
|
4.65% | -- | -- |
Thermo Fisher Scientific Inc
|
3.98% | -- | -- |
Intercontinental Exchange Inc
|
3.87% | -- | -- |
Basic Info
Investment Strategy | |
The fund seeks to maximize long-term capital appreciation primarily through exposure to a portfolio of growth-oriented equities issued by companies located anywhere in the world. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | CIG90198 |
Equity Style | Large Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | -- |
Broad Category | Equity |
Category Name | Global Equity |
Category Index | Morningstar Gbl Mkts GR CAD |
Prospectus Objective | -- |
Fund Owner Firm Name | CI Investments Inc |
Prospectus Benchmark Index | |
MSCI ACWI NR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPTSX60TR | 100.0% |
Manager Tenure | |
James Tsinidis | 3.30 yrs |
Jeremy Gibson | 3.30 yrs |
Kieran Moore | 3.30 yrs |
Nick Griffin | 3.30 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (5-19-22) | 0.00% |
30-Day SEC Yield | -- |
7-Day SEC Yield | -- |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 29.54 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of April 30, 2022
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 8/10/2020 |
Last Annual Report Date | 3/31/2021 |
Last Prospectus Date | -- |
Share Classes | |
CIG2198 | Commission-based Advice |
CIG2199 | Commission-based Advice |
CIG4199 | Fee-based Advice |
CIG5341 | Institutional |
CIG90198 | Fee-based Advice |
F000016CAR | Institutional |
F000016CAS | Fee-based Advice |
Attributes | |
Enhanced Index Fund | No |
Index Fund | No |
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |